Gastroenterology Research and Practice · 2015 · 31 citations · 31 references
MedicineClinical SciencesPathologyAnatomic PathologyGastroenterologyHistopathologyColonic DiseasesGastrointestinal EndoscopyGastrointestinal InflammationGastrointestinal PathologyInflammatory Bowel DiseaseInflammatory LesionsC-reactive Protein TestingClinical RemissionColonic PathologyEndoscopic Inflammation AssessmentInflammatory Bowel Disease Activity AssessmentInflammatory Bowel Disease EndoscopyMedical Records ReviewUlcerative Colitis Pathology
Objectives. Recent studies suggest that histological healing is a treatment goal in ulcerative colitis (UC). We aimed to evaluate the correlation between histological activity and clinical, endoscopic, and serologic activities in patients with UC. Methods. We retrospectively reviewed medical records from patients with UC who underwent colonoscopy or sigmoidoscopy with biopsies. The Mayo endoscopic subscore was used to assess endoscopic activity. Biopsy specimens were reviewed by two blinded pathologists and scored using the Geboes scoring system. Results. We analyzed 154 biopsy specimens from 82 patients with UC. Histological scores exhibited strong correlation with endoscopic subscores (Spearman's rank correlation coefficient r = 0.774, p < 0.001) and moderate correlation with C-reactive protein levels (r = 0.422, p < 0.001) and partial Mayo scores (r = 0.403, p < 0.001). Active histological inflammation (Geboes score ≥ 3.1) was observed in 6% (2 of 33) of the endoscopically normal mucosa samples, 66% (19 of 29) of mild disease samples, and 98% (90 of 92) of moderate-to-severe disease samples. Conclusions. Histological activity was closely correlated with the endoscopic, clinical, and serologic UC activities. However, several patients with mild or normal endoscopic findings exhibited histological evidence of inflammation. Therefore, histological assessment may be helpful in evaluating treatment outcomes and determining follow-up strategies.
31
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Matthew D. Rutter, Brian P. Saunders, Kay H. Wilkinson et al. · Gastroenterology · 2004 · 1.3K citations
Medicine, Immunology, Oncology +16